JWCTFJW CAYMAN THERAPEUTICS CO LTD.

About JW CAYMAN THERAPEUTICS CO LTD. (JWCTF)

JW CAYMAN THERAPEUTICS CO LTD. (JWCTF) is a Biotechnology company whose shares trade over-the-counter on the Pink tier.

JW (Cayman) Therapeutics Co. Ltd (the "Company") is a global leading clinical stage cell therapy platform company. The Company's vision is to develop best-in-class and/or first-in-class cell therapies for the China market to transform the treatment of cancer for Chinese patients. Since the establishment of JW Shanghai in 2016 , it has built an integrated platform focused on developing, manufacturing and commercializing breakthrough cell-based immunotherapies for hematological cancers and solid tumors.

JWCTF key facts

Ticker symbol

JWCTF

Market tier

Pink

Sector

Healthcare

Industry

Biotechnology

Country of incorporation

KY

Estimated market cap

$810.00M (as of May 12, 2025)

Shares outstanding

5,000,000,000

Reporting standard

International Reporting: Hong Kong Stock Exchange

Audit status

Not Available

Explore more: Biotechnology stocks · Healthcare sector · Pink stocks · OTC stocks starting with J